ResearcherUniversity of PisaActive in the last 2 years

Asia Botto

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3135-2303; OpenAlex author ID A5090860966. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 10

Papers, trials and grants by year

2024: 1 paper · 2025: none · 2026: 1 paper

Papers 2

Proteomics of Extracellular Vesicles Derived from Primary Cells of Pancreatic Ductal Adenocarcinoma Patients Identifies Ribosomal Proteins Associated with Surv… Co-author DOI 10.1021/acs.jproteome.6c00168 ↗
ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pancreatic cancer cells. Co-author DOI 10.1186/s13046-023-02879-8 ↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Liam Andrew McDonnell · 2 shared papers, 2024–2026 · strength 0.51
- Paper Proteomics of Extracellular Vesicles Derived from Primary Cells of Pancreatic Ductal Adenocarcinoma Patients Identifies… DOI 10.1021/acs.jproteome.6c00168 ↗
- Paper ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pan… DOI 10.1186/s13046-023-02879-8 ↗
Elisa Giovannetti · 2 shared papers, 2024–2026 · strength 0.51
- Paper Proteomics of Extracellular Vesicles Derived from Primary Cells of Pancreatic Ductal Adenocarcinoma Patients Identifies… DOI 10.1021/acs.jproteome.6c00168 ↗
- Paper ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pan… DOI 10.1186/s13046-023-02879-8 ↗
Annalisa Comandatore · 1 shared paper, 2026 · strength 0.33
- Paper Proteomics of Extracellular Vesicles Derived from Primary Cells of Pancreatic Ductal Adenocarcinoma Patients Identifies… DOI 10.1021/acs.jproteome.6c00168 ↗
Luca Morelli · 1 shared paper, 2026 · strength 0.33
- Paper Proteomics of Extracellular Vesicles Derived from Primary Cells of Pancreatic Ductal Adenocarcinoma Patients Identifies… DOI 10.1021/acs.jproteome.6c00168 ↗
Thomas Schmidt · 1 shared paper, 2024 · strength 0.18
- Paper ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pan… DOI 10.1186/s13046-023-02879-8 ↗
Erik H.J. Danen · 1 shared paper, 2024 · strength 0.18
- Paper ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pan… DOI 10.1186/s13046-023-02879-8 ↗
Cecilia Bergonzini · 1 shared paper, 2024 · strength 0.18
- Paper ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pan… DOI 10.1186/s13046-023-02879-8 ↗
Mjriam Capula · 1 shared paper, 2024 · strength 0.18
- Paper ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pan… DOI 10.1186/s13046-023-02879-8 ↗
Ingrid Garajová · 1 shared paper, 2024 · strength 0.18
- Paper ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pan… DOI 10.1186/s13046-023-02879-8 ↗
Alessandro Gregori · 1 shared paper, 2024 · strength 0.18
- Paper ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pan… DOI 10.1186/s13046-023-02879-8 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.